ArticleOncotarget2017

CBP501 inhibits EGF-dependent cell migration, invasion and epithelial-to-mesenchymal transition of non-small cell lung cancer cells by blocking KRas to calmodulin binding.

Naoya Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.